Literature DB >> 3013672

Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells.

G Ribéreau-Gayon, M L Jung, S Baudino, G Sallé, J P Beck.   

Abstract

Bacterially fermented mistletoe preparations (BFMP) were tested on rat hepatoma tissue culture (HTC) cells and human leukemia Molt 4 cells. A dose-dependent inhibition of the growth rate of the cells was observed. For both cell lines, cytostatic concentrations, expressed in weight of fresh plant, were 0.5 mg/ml culture medium for oak BFMP and 1 mg/ml for apple tree BFMP. However, the action of the two preparations was markedly different on each cell line. Non-viable HTC cells were not stained by trypan blue while non-viable Molt 4 cells were fully colored by this reagent. A lysis of cellular membranes of HTC cells was observed by electron microscopy. Furthermore, oak BFMP inhibited the growth of virus transformed 3T3-SV40 cells more than that of non-transformed 3T3 cells. In contrast to BFMP, non-fermented extracts and a purified mistletoe lectin showed a greater inhibition of the growth of Molt 4 cells than of HTC cells. Samples withdrawn at different times during fermentation gradually lost their inhibitory effect on the growth of Molt 4 cells while their action on HTC cells increased up to the 4th day of fermentation. These results are discussed in relation to the cytotoxic substances of mistletoe already characterized.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013672     DOI: 10.1007/bf01955552

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  15 in total

1.  Counting actively metabolizing tissue cultured cells.

Authors:  H J PHILLIPS; J E TERRYBERRY
Journal:  Exp Cell Res       Date:  1957-10       Impact factor: 3.905

2.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

3.  Inhibitory effects of a protein complex from Viscum album on fibroblasts and HeLa cells.

Authors:  O Klamerth; F Vester; G Kellner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1968-06

4.  "Contact inhibition" of cell division in 3T3 cells.

Authors:  R W Holley; J A Kiernan
Journal:  Proc Natl Acad Sci U S A       Date:  1968-05       Impact factor: 11.205

5.  Cellular and humoral adjuvant activity of mistletoe extract.

Authors:  N Bloksma; H Van Dijk; P Korst; J M Willers
Journal:  Immunobiology       Date:  1979-09       Impact factor: 3.144

6.  [Ingredients of mistletoe (Viscum album L.) as potential drugs].

Authors:  H Franz
Journal:  Pharmazie       Date:  1985-02       Impact factor: 1.267

7.  Action of viscumin, a toxic lectin from mistletoe, on cells in culture.

Authors:  F Stirpe; K Sandvig; S Olsnes; A Pihl
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

8.  Isolation of viscotoxins. Cytotoxic basic polypeptides from Viscum album L.

Authors:  J Konopa; J M Woynarowski; M Lewandowska-Gumieniak
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-10

9.  Isolation and properties of three lectins from mistletoe (Viscum album L.).

Authors:  H Franz; P Ziska; A Kindt
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

10.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  3 in total

1.  Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.

Authors:  G Stein; P A Berg
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

2.  A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia.

Authors:  C I Delebinski; S Jaeger; K Kemnitz-Hassanin; G Henze; H N Lode; G J Seifert
Journal:  Cell Prolif       Date:  2012-01-03       Impact factor: 6.831

3.  Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.

Authors:  M Mabed; L El-Helw; S Shamaa
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.